# COVID19 Drug Discovery Consortium
Repository for COVID19 drug discovery research
The COVID-19 Drug Discovery Consortium (DDC) is multi-institutional and a multi-disciplinary group of researchers, scholars, and professionals. The consortium is on a mission to quickly bring drug molecules to the market for the treatment of COVID19.

#Team
##Founders
* Suman Sirimulla, University of Texas at El Paso 
* Stanley Watowich, University of Texas Medical Branch
* Francisco J. Enguita, University of Lisbon
* Mark White, University of Texas Medical Branch
* Xiaodong Cheng,  MD Anderson Cancer center
* Joe Allen, Texas Advanced Computing Center, UT Austin 
* Ritu Arora, Texas Advanced Computing Center, UT Austin

##Members
* Josh T Beckham, University of Texas at Austin
* Rodrigo Ochoa, University of Antioquia Colombia
* Yun Lyna Luo, Western University of Health Sciences
* Amit Gupta, Texas Medical Center Innovation Institute, Houston
* Jin Wang, Baylor College of Medicine
* JoAnne Babula, Ridgeline Therapeutics
* Lisheng Deng, Baylor College of Medicine
* Filip Fratev, Micar21
* Adrian Varela-Alvarez, University of Texas at El Paso

##Partners
* Enamine
* Texas A&M Institute for Biosciences & Technology
* Boston Universityâ€™s National Emerging Infectious Diseases Laboratories(NEIDL)
